美国妇产科医师学会与母胎医学会产前诊断指南:核型分析真的足够吗?
该研究评估了3223例接受染色体微阵列分析(CMA)的产前样本,按美国妇产科医师学会(ACOG)指南分为需CMA组和可选CMA或核型分析组。在可选CMA或核型分析的患者中,2.5%存在若选择核型分析将被漏诊的临床显著染色体异常(CSCA)。研究提示若指南继续认为无胎儿结构异常时CMA与核型分析诊断价值等同,这部分CSCA可能被漏诊。
要点
- 3223例产前样本中,1475例(45.8%)符合ACOG指南推荐CMA的指征。
- 1748例(54.2%)符合ACOG指南推荐CMA或核型分析的指征。
- 在可选CMA或核型分析的患者中,2.5%存在若选核型分析将被漏诊的CSCA。
核心结论
- 该研究提示,若指南继续建议对无胎儿结构异常的患者CMA与核型分析具有等同诊断价值,2.5%的患者可能存在被漏诊的临床显著染色体异常(CSCA)。
研究设计与样本
- 研究评估了3223例接受染色体微阵列分析(CMA)的产前样本,按ACOG指南分为符合CMA推荐组和符合CMA或核型分析推荐组。
主要发现
- 3223例中,1475例(45.8%)符合ACOG推荐CMA的指征,1748例(54.2%)符合推荐CMA或核型分析的指征。
- 在可选CMA或核型分析的患者中,2.5%存在若选择核型分析将被漏诊的CSCA。
关键数值与推荐
- ACOG与SMFM推荐对1个或多个胎儿结构异常者行产前诊断时采用CMA。
- 对选择产前诊断且胎儿结构正常的患者,ACOG与SMFM推荐CMA或核型分析均可。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The American College of Obstetricians and Gynecologists (ACOG) and Society for Maternal-Fetal Medicine (SMFM) recommend chromosomal microarray analysis (CMA) for prenatal diagnosis in cases with 1 or more fetal structural abnormalities. For patients who elect prenatal diagnosis and have a structurally normal fetus, either microarray or karyotype is recommended. This study evaluates the frequency of clinically significant chromosomal abnormalities (CSCA) that would have been missed if all patients offered the choice between CMA and karyotyping chose karyotyping. METHODS: A total of 3223 prenatal samples undergoing CMA were evaluated. Cases were categorized into 2 groups: those that met ACOG guidelines for CMA versus those that met ACOG guidelines for either CMA or karyotype. RESULTS: Of the 3223 cases, 1475 (45.8%) met ACOG recommendations for CMA, and 1748 (54.2%) met recommendations for either CMA or karyotype. In patients who could have elected either CMA or karyotype, 2.5% had CSCA that would have been missed if the patient had elected to pursue karyotype. CONCLUSION: This study suggests that 2.5% of patients will have a CSCA that may be missed if the guidelines continue to suggest that CMA and karyotyping have equivalent diagnostic value for patients without a fetal structural abnormality.
引用
- Hay SB, Sahoo T, Travis MK, et al. ACOG and SMFM guidelines for prenatal diagnosis: Is karyotyping really sufficient? Prenat Diagn. 2018. PMID: 29315677. doi:10.1002/pd.5212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。